期刊文献+

免疫抑制剂在IgA肾病的应用研究进展 被引量:5

原文传递
导出
摘要 IgA肾病(IgAN)是我国最常见的原发性肾小球疾病,其临床症状、病理特征和预后均呈多样性。免疫抑制剂,如环孢素A、来氟米特、霉酚酸酯、环磷酰胺等的使用对本病的治疗有一定的缓解。近几年该病在免疫抑制剂的治疗应用上有较大进展。本文将近几年来免疫抑制剂治疗IgA肾病的应用进展进行总结。
作者 颜天铭 杨波
出处 《社区医学杂志》 2013年第2期69-70,共2页 Journal Of Community Medicine
  • 相关文献

参考文献12

  • 1孙珉丹,林承赫,袁彤.来氟米特治疗IgA肾病的临床观察[J].中国老年学杂志,2009,29(16):2038-2039. 被引量:9
  • 2苏醒,包蓓艳,尤晓青.来氟米特治疗HassⅢ~Ⅳ期IgA肾病的效果[J].现代实用医学,2009,21(11):1182-1182. 被引量:5
  • 3王维平,张玉强.来氟米特治疗表现为难治性肾病综合征的IgA肾病临床分析[J].中国中西医结合肾病杂志,2010,11(10):906-908. 被引量:13
  • 4Liu XW,Li DM,Xu GS. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome[J].Int J Clin Pharnacol Ther,2010,(08):509-513.
  • 5Oshima S,Kawamura O. Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphmide therapy[J].Clinical and Experimental Nephrology,2008,(04):264-269.
  • 6Pozzi C,Andrulli S,Pani A. Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy[J].Journal of the American Society of Nephrology,2010,(10):1783-1790.
  • 7Tan CHR,Loh PT,Yang WS,Chan CM. Mycophenolate mofetil in the treatment of IgA nephropathy:a systematic review[J].SingaporeMed,2008,(10):780-785.
  • 8陈喜生,张丽.吗替麦考酚酯联合缬沙坦治疗IgA肾病的临床研究[J].中国医药指南,2010,8(20):53-54. 被引量:14
  • 9Tang SC,Tang AW,Wong SS. Long-term study of mycopheno-late mofetil treatment in IgA nephropathy[J].Kidney International,2010,(06):543.
  • 10Yoshikawa N,Honda M,Iijima K. Steroid treatment for severe childhood IgA nephropathy:a randomized,controlled Trial[J].Clin J Am Soc Nephrol,2006,(03):511-517.

二级参考文献29

  • 1李雄根,贺晓蕾,沈倍义,陈化蓉,张欣洲,易铁刚.来氟米特治疗以肾病综合征为主的IgA肾病临床分析[J].河北医学,2005,11(6):501-502. 被引量:3
  • 2张杰,何俊,李正良,申兵冰,刘先蓉,沙朝晖,钟慧,夏妮娅,黄颂敏.来氟米特治疗IgA肾病的临床研究[J].中国实用内科杂志,2005,25(7):628-630. 被引量:25
  • 3Donadio JV,Grande JP. IgA nephropathy[J]. N Engl J Med,2002 ;347: 738-48.
  • 4D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome[ J]. Sem in Nephrol,2004 ;24:179-96.
  • 5Barratt J, Feehally J. IgA nephropathy[ J ]. J Am Soc N ephrol,2005;16: 2088 -97.
  • 6Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy : long-term results of a randomized, controlled trial [ J]. J Am SocNephrol 2004 ; 15 : 157-63.
  • 7Rasche FM, Keller F, von Muller L, et al. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy[J]. J Nephrol, 2006 ; 19:465-72.
  • 8Strauss G, Osen W, Debatin KM. Induction of apoptosis and modulation of activation and effector function in T cell by immunosuppressive drugs. Clin Exp Immunol,2002,128:255-266.
  • 9Yang B,Jain S,Ashra SY,et al. Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rat and divergent effects of immunosuppressants. Transplantation, 2006,81:1442- 1450.
  • 10SJ Choi, HS You, SY Chung. Tacrolimus-induced apoptotic signal transduction pathway. Transplant proc, 2008,40:2734 -2736.

共引文献41

同被引文献31

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部